Haemophilus Influenzae Type B Vaccine Market Report

Global and Region Haemophilus Influenzae Type B Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：153
  • REPORT CODE：GMM933300
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Haemophilus Influenzae Type B Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Haemophilus Influenzae Type B Vaccinemarket, defines the market attractiveness level of Haemophilus Influenzae Type B Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Haemophilus Influenzae Type B Vaccine industry, describes the types of Haemophilus Influenzae Type B Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Haemophilus Influenzae Type B Vaccine market and the development prospects and opportunities of Haemophilus Influenzae Type B Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Haemophilus Influenzae Type B Vaccine market in Chapter 13.

    By Player:

    • Novartis

    • GlaxoSmithKline

    • Lanzhou Institute of Biologica

    • Walvax Biotechnology

    • Merck

    • Immunize BC

    • Sanofi

    • Takeda Pharmaceuticals Company

    By Type:

    • Liquid Monovalent HIB

    • Liquid Combination HIB

    • Lyophilized Monovalent HIB

    • Lyophilized Combination HIB

    By End-User:

    • Hospital

    • Research Institutions

    • Pharmaceutical and Biotechnology Companies

    • Academic Institutions

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Haemophilus Influenzae Type B Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Haemophilus Influenzae Type B Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Haemophilus Influenzae Type B Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Haemophilus Influenzae Type B Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Haemophilus Influenzae Type B Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.2 United States Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.3 Europe Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.4 China Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.5 Japan Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.6 India Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    • 7.7 South Korea Haemophilus Influenzae Type B Vaccine Consumption (2017-2022)

    8 Region and Country-wise Haemophilus Influenzae Type B Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Haemophilus Influenzae Type B Vaccine Consumption Forecast (2022-2028)

    9 Global Haemophilus Influenzae Type B Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liquid Monovalent HIB Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Liquid Combination HIB Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lyophilized Monovalent HIB Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Lyophilized Combination HIB Consumption and Growth Rate (2017-2022)

    • 9.2 Global Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Institutions Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmaceutical and Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic Institutions Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Haemophilus Influenzae Type B Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liquid Monovalent HIB Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Liquid Combination HIB Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Lyophilized Monovalent HIB Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Lyophilized Combination HIB Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Institutions Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Pharmaceutical and Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Academic Institutions Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Haemophilus Influenzae Type B Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Haemophilus Influenzae Type B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Haemophilus Influenzae Type B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Haemophilus Influenzae Type B Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Haemophilus Influenzae Type B Vaccine Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.3 Lanzhou Institute of Biologica

      • 14.3.1 Lanzhou Institute of Biologica Company Details

      • 14.3.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.4 Walvax Biotechnology

      • 14.4.1 Walvax Biotechnology Company Details

      • 14.4.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.6 Immunize BC

      • 14.6.1 Immunize BC Company Details

      • 14.6.2 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Immunize BC Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Haemophilus Influenzae Type B Vaccine Product and Service

    • 14.8 Takeda Pharmaceuticals Company

      • 14.8.1 Takeda Pharmaceuticals Company Company Details

      • 14.8.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Haemophilus Influenzae Type B Vaccine

    • Figure Haemophilus Influenzae Type B Vaccine Picture

    • Table Global Haemophilus Influenzae Type B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Haemophilus Influenzae Type B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Haemophilus Influenzae Type B Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Haemophilus Influenzae Type B Vaccine Consumption by Country (2017-2022)

    • Figure United States Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Haemophilus Influenzae Type B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Haemophilus Influenzae Type B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Haemophilus Influenzae Type B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liquid Monovalent HIB Consumption and Growth Rate (2017-2022)

    • Figure Global Liquid Combination HIB Consumption and Growth Rate (2017-2022)

    • Figure Global Lyophilized Monovalent HIB Consumption and Growth Rate (2017-2022)

    • Figure Global Lyophilized Combination HIB Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutions Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical and Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Institutions Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Liquid Monovalent HIB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liquid Combination HIB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lyophilized Monovalent HIB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lyophilized Combination HIB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical and Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Institutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Haemophilus Influenzae Type B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Haemophilus Influenzae Type B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Haemophilus Influenzae Type B Vaccine Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Lanzhou Institute of Biologica (Foundation Year, Company Profile and etc.)

    • Table Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Walvax Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Immunize BC (Foundation Year, Company Profile and etc.)

    • Table Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunize BC Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Haemophilus Influenzae Type B Vaccine Product and Service

    • Table Takeda Pharmaceuticals Company (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US